BACKGROUND: Ophthalmological complications in patients with mucopolysaccharidosis (MPS) are clouding of the cornea, glaucoma, optic neuropathy, and degeneration of the retina. These changes may impair visual function to the point of total loss of vision. OBJECTIVE: To document the ophthalmological changes demonstrated by grey-scale US in patients with MPS. MATERIALS AND METHODS: A total of 65 patients with MPS (18 type I, 12 type II, 35 type VI) including a subgroup of 30 undergoing enzyme replacement therapy (ERT) were studied by US of the globe and optic nerve. RESULTS: Average scleral thickness at the posterior pole of the globe measured 2.02-2.58 mm (normal range 1.4-1.7 mm), the average diameter of the optic nerve and its sheath measured 5.35-6.71 mm (normal <4.5 mm). All medians were statistically significantly different from those of healthy volunteers. Concomitantly there was hypermetropia of up to 7.5 dioptres. During a mean follow-up of 3.1 years there was no distinct progression in scleral or optic nerve complex thickness. CONCLUSION: The optic nerve sheath and sclera were clearly thickened in comparison to normal values. Many morphological changes in the eye and optic nerve were already present at the time of the initial clinical diagnosis, and thus seem to develop very early in the course of the disease. ERT in our patients did not seem to alter the US characteristics of the globe or optic nerve.
BACKGROUND: Ophthalmological complications in patients with mucopolysaccharidosis (MPS) are clouding of the cornea, glaucoma, optic neuropathy, and degeneration of the retina. These changes may impair visual function to the point of total loss of vision. OBJECTIVE: To document the ophthalmological changes demonstrated by grey-scale US in patients with MPS. MATERIALS AND METHODS: A total of 65 patients with MPS (18 type I, 12 type II, 35 type VI) including a subgroup of 30 undergoing enzyme replacement therapy (ERT) were studied by US of the globe and optic nerve. RESULTS: Average scleral thickness at the posterior pole of the globe measured 2.02-2.58 mm (normal range 1.4-1.7 mm), the average diameter of the optic nerve and its sheath measured 5.35-6.71 mm (normal <4.5 mm). All medians were statistically significantly different from those of healthy volunteers. Concomitantly there was hypermetropia of up to 7.5 dioptres. During a mean follow-up of 3.1 years there was no distinct progression in scleral or optic nerve complex thickness. CONCLUSION: The optic nerve sheath and sclera were clearly thickened in comparison to normal values. Many morphological changes in the eye and optic nerve were already present at the time of the initial clinical diagnosis, and thus seem to develop very early in the course of the disease. ERT in our patients did not seem to alter the US characteristics of the globe or optic nerve.
Authors: F Baehner; C Schmiedeskamp; F Krummenauer; E Miebach; M Bajbouj; C Whybra; A Kohlschütter; C Kampmann; M Beck Journal: J Inherit Metab Dis Date: 2005 Impact factor: 4.982
Authors: Paul Harmatz; Roberto Giugliani; Ida Schwartz; Nathalie Guffon; Elisa Leão Teles; M Clara Sá Miranda; J Edmond Wraith; Michael Beck; Laila Arash; Maurizio Scarpa; Zi-Fan Yu; Janet Wittes; Kenneth I Berger; Mary S Newman; Ann M Lowe; Emil Kakkis; Stuart J Swiedler Journal: J Pediatr Date: 2006-04 Impact factor: 4.406
Authors: James E Wraith; Lorne A Clarke; Michael Beck; Edwin H Kolodny; Gregory M Pastores; Joseph Muenzer; David M Rapoport; Kenneth I Berger; Stuart J Swiedler; Emil D Kakkis; Tanja Braakman; Elenie Chadbourne; Karen Walton-Bowen; Gerald F Cox Journal: J Pediatr Date: 2004-05 Impact factor: 4.406
Authors: Joseph Muenzer; James E Wraith; Michael Beck; Roberto Giugliani; Paul Harmatz; Christine M Eng; Ashok Vellodi; Rick Martin; Uma Ramaswami; Muge Gucsavas-Calikoglu; Suresh Vijayaraghavan; Susanne Wendt; Suzanne Wendt; Ana Cristina Puga; Antonio Puga; Brian Ulbrich; Marwan Shinawi; Maureen Cleary; Diane Piper; Anne Marie Conway; Ann Marie Conway; Alan Kimura Journal: Genet Med Date: 2006-08 Impact factor: 8.822
Authors: Roberto Giugliani; Andressa Federhen; Maria Verônica Muñoz Rojas; Taiane Vieira; Osvaldo Artigalás; Louise Lapagesse Pinto; Ana Cecília Azevedo; Angelina Acosta; Carmen Bonfim; Charles Marques Lourenço; Chong Ae Kim; Dafne Horovitz; Denize Bonfim; Denise Norato; Diane Marinho; Durval Palhares; Emerson Santana Santos; Erlane Ribeiro; Eugênia Valadares; Fábio Guarany; Gisele Rosone de Lucca; Helena Pimentel; Isabel Neves de Souza; Jordão Correa; José Carlos Fraga; José Eduardo Goes; José Maria Cabral; José Simionato; Juan Llerena; Laura Jardim; Liane Giuliani; Luiz Carlos Santana da Silva; Mara L Santos; Maria Angela Moreira; Marcelo Kerstenetzky; Márcia Ribeiro; Nicole Ruas; Patricia Barrios; Paulo Aranda; Rachel Honjo; Raquel Boy; Ronaldo Costa; Carolina Souza; Flavio F Alcantara; Silvio Gilberto A Avilla; Simone Fagondes; Ana Maria Martins Journal: Genet Mol Biol Date: 2010-12-01 Impact factor: 1.771
Authors: Çağri Damar; Betül Emine Derinkuyu; Muazzez Asburçe Bike Olgaç Kiliçkaya; Mehmet Öztürk; Çiğdem Öztunali; Ayşe Gül Alimli; Öznur Leman Boyunaga; Murat Uçar; Fatih Süheyl Ezgü; Leyla Tümer; Alp Özgün Börcek; Ahmet Siğirci Journal: Turk J Med Sci Date: 2020-02-03 Impact factor: 0.973
Authors: Christiane S Hampe; Julie B Eisengart; Troy C Lund; Paul J Orchard; Monika Swietlicka; Jacob Wesley; R Scott McIvor Journal: Cells Date: 2020-08-05 Impact factor: 6.600